• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • 2022 NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2023 Scientific Session Call For Abstracts
      • 2023 Emerging Technology Call For Abstracts
    • SAGES 2021 Annual Meeting
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2021
      • SAGES 2020
      • SAGES 2019
      • SAGES 2018
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Blog
    • COVID-19
    • Notes from the Battlefield
    • A (Positive) Way Forward
    • President Posts
    • All Blog Posts
  • Log In

Gastrointestinal Stromal Tumor (GIST)

First submitted by:
Shawn Tsuda
Category
Stomach and Foregut
Print Friendly, PDF & Email

OVERVIEW

• Gastrointestinal stromal tumor (GISTs) are the most common mesenchymal tumor of the GI tract and originate from the intestinal pacemaker cells, the interstitial cells of Cajal. It is distinguished from other mesenchymal tumors (e.g. leiomyoma, schwannoma) through immunohistochemistry identifying markers of GIST, which are equally expressed in interstitial cells of Cajal: CD117 (KIT) – gene product of stem cell factor receptor proto-oncogene c-kit; CD34 – hematopoietic progenitor cell antigen; PDGF receptor alpha (PDGFRA) – alternative and mutually exclusive oncogenic mechanisms to c-kit pathway.

EPIDEMIOLOGY

• GISTs constitute 0.1–3% of all GI neoplasms. The estimated annual incidence is 10–15 new cases per million people or approximately 3,000 to 5,000 new cases in the US yearly. Although GISTs may occur at all ages, the peak incidence is in the sixth decade of life, with a slight male predominance.
• More than half of GISTs start in the stomach 50-60%. Other locations include the small intestine 25–30% (ileum>jejunum>duodenal), colon/rectum/rectovaginal septum 2–10%, esophagus 9%. Less common locations include retroperitoneal, pancreas, etc.
• Up to 50% of GISTs are metastatic or multifocal at the time of presentation.

PATHOLOGY

• The malignant potential of GISTs is difficult to assess even after pathologic review.
• Favorable prognostic factors include: gastric location, < 5 cm in diameter, mitotic index 5 mitoses per 10 HPFs, absence of necrosis, low proliferating cell nuclear antigen, Ki-67 analogue index < 10%, confined tumor, lack of metastasis to other sites.
• Unfavorable prognostic factors include: esophageal/colonic/rectal location, > 10 cm in diameter, mitotic index 10 mitoses per 10 HPFs, presence of coagulative necrosis, invasion of adjacent organs, evidence of peritoneal seeding or distant metastases.

 

CLINICAL PRESENTATION

• GISTs can either be asymptomatic, found incidentally at the time of GI evaluation by either endoscopic or contrast studies, at operation, or may cause life-threatening symptoms.
• Symptoms are site specific and include: dysphagia for tumors of the esophagus, nausea and vomiting caused by gastric outlet obstruction for gastric tumors, obstructive jaundice for periampullary tumors, and bowel obstruction usually caused by intussusceptions for tumors of the small bowel and colon. In up to 20% of patients, an asymptomatic abdominal mass is the presenting complaint.

DIAGNOSIS
• As part of the analysis, blood tests and CT scanning are often undertaken.
• A biopsy sample will be investigated under the microscope. The histopathologist identifies the characteristics of GISTs (spindle cells in 70-80%, epitheloid aspect in 20-30%). Smaller tumors can usually be found to the muscularis propria layer of the intestinal wall. Large ones grow, mainly outward, from the bowel wall until the point where they outstrip their blood supply and necrose (die) on the inside, forming a cavity that may eventually come to communicate with the bowel lumen.
• When GIST is suspected—as opposed to other causes for similar tumors—the pathologist can use immunohistochemistry (specific antibodies that stain the molecule CD117 (also known as c-kit) —see below). 95% of all GISTs are CD117-positive (other possible markers include CD34, DOG-1, desmin, vimentin and others). Other cells that show CD117 positivity are mast cells.
• If the CD117 stain is negative and suspicion remains that the tumor is a GIST, the newer antibody DOG-1 (Discovered On GIST-1) can be used. Also sequencing of Kit and PDGFRA can be used to prove the diagnosis.
• Barium fluoroscopic examinations (upper GI series and small bowel series) and CT are commonly used to evaluate the patient with upper abdominal pain. Both are adequate to make the diagnosis of GIST, although small tumors may be missed, especially in cases of a suboptimal examination.
• Small GISTs appear as intramural masses. When large (> 5 cm), they most commonly grow outward from the bowel. Internal calcifications may be present. As the tumor outstrips its blood supply, it can necrose internally, creating a central fluid-filled cavity that can eventually ulcerate into the lumen of the bowel or stomach.
• The tumor can directly invade adjacent structures in the abdomen. The most common site of spread is to the liver. Spread to the peritoneum may be seen. In distinction to gastric adenocarcinoma or gastric/small bowel lymphoma, malignant adenopathy (swollen lymph nodes) is uncommon (<10%).

 

NON-SURGICAL TREATMENT

• Medical therapy
o Recurrent and locally advanced or metastatic tumors are increasingly treated with imatinib (Gleevec) in palliative, adjuvant, or neoadjuvant setting. Tumor response imatinib correlates with expression of CD117 (c-kit). Disease control is achieved in 70–85% of patients with unresectable or metastatic disease and is associated with prolonged progression-free survival and overall survival (median 36 months); 90% disease-free survival in adjuvant setting after curative resection of GIST.
o Another medical treatment involves sunitinib for imatinib-resistant GISTs.
• Radiation therapy
o Presently there is no defined role for radiation therapy.

 

SURGICAL TREATMENT

• GISTs are highly resistant to conventional chemotherapy. Treatment is primarily surgical resection of localized GIST with 1 cm margin.
• The operative approach is en-bloc resection of tumor-involved organ with inclusion of intact pseudocapsule. Radical lymphadenectomy is not routinely indicated as lymph node involvement less than 10%. Even in the presence of metastases, the primary tumor should be resected if possible for palliation of symptoms and to prevent development of complications such as obstruction, etc. Independent risk factors that predict recurrence include male gender, presence of deletion or insertion c-kit exon 11 mutations, high mitotic rate, and mixed cytomorphology.

5,174

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

Category: Stomach and Foregut
  • Main Page
  • Help
  • Create a New Wiki

Our Mission

Innovate, educate and collaborate to improve patient care.

Recently, on SAGES…

Surgery is Safer with Vaccination 1

Addressing Religious Concerns About COVID-19 Vaccine

This may be a difficult subject matter for you and your patient to talk about.  Be assured, all major organized religious groups encourage and recommend the COVID-19 vaccine. Listed below are references and websites you can direct your patient towards to help them make an informed decision with regards to their religious concerns against the […]

SAGES Statement on AAPI Violence

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) stands in solidarity with the Asian American and Pacific Islander (AAPI) community. In the summer of 2020, SAGES released a statement condemning the violence, racism, and hatred toward the Black community in the wake of George Floyd and Breonna Taylor’s murders. It is with great sorrow […]

Free SAGES Webinar: Lessons from COVID on Living and Thriving as Surgeons

SAGES recognizes that the COVID-19 pandemic has had a big impact on surgical practice and in surgeon wellness. SAGES’ Reimagining the Practice of Surgery Taskforce will present “Finding the Opportunities: Lessons from COVID and How We Live and Thrive as Surgeons”  to look at ways in which innovative leadership at various levels may help transform […]

Contact SAGES

Society of American Gastrointestinal and Endoscopic Surgeons
11300 W. Olympic Blvd Suite 600
Los Angeles, CA 90064 USA
[email protected]
Tel: (310) 437-0544

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2022 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2022 Society of American Gastrointestinal and Endoscopic Surgeons